We are live on ! Find out more
CYTHW

Cyclo Therapeutics, Inc. Warrant

Delisted

CYTHW was delisted on the 25th of March, 2025.

2 hedge funds and large institutions have $337K invested in Cyclo Therapeutics, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 62 (-4)

84% less capital invested

Capital invested by funds: $2.05M → $337K (-$1.71M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-4
Holders Change %
-66.67%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WVP
1
Worth Venture Partners
New Jersey
$333K
UBS Group
2
UBS Group
Switzerland
$4K -$3.27K -855 -46%
ACM
3
AIGH Capital Management
Maryland
-$1.52M -350,000 Closed
SM
4
Sabby Management
Florida
-$208K -193,012 Closed
CH
5
CVI Holdings
Delaware
-$64K -59,000 Closed
AC
6
Armistice Capital
New York
-$156K -50,000 Closed

CYTHW Hedge Fund Activity: Q1 2021 in Review

2 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q1 2021, worth a combined $337K — down 84% from $2.05M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CYTHW and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was AIGH Capital Management, exiting entirely with an estimated $1.52M sold.

  • 2 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q1 2021, down from 6 in Q4 2020.
  • Funds reported $337K of Cyclo Therapeutics, Inc. Warrant stock for Q1 2021, down 84% quarter-over-quarter.
  • 0 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q1 2021 and 4 closed out, a net change of -4 holders.
  • The largest Cyclo Therapeutics, Inc. Warrant seller in Q1 2021 was AIGH Capital Management, an estimated $1.52M sold.

Based on aggregated 13F filings for Q1 2021.